The World Health Organization classifies HIV progression into four clinical stages, from Stage 1 (asymptomatic) to Stage 4 (severely symptomatic, equivalent to AIDS). This system was designed for resource-limited settings where lab testing may not be available, allowing healthcare workers to assess how far HIV has progressed based on symptoms and clinical conditions alone. It remains widely used across Africa, Southeast Asia, and other regions, and it guides decisions about when to start treatment and how aggressively to manage complications.
How the WHO Staging System Works
Unlike the CDC’s classification used in the United States, which relies heavily on CD4 cell counts from blood tests, the WHO system can be applied using only a physical exam and patient history. A clinician looks at what symptoms and infections a person has developed and assigns the highest stage that matches. The staging only moves forward: once someone is classified at Stage 3, they stay at Stage 3 or higher even if symptoms improve with treatment.
CD4 testing is now the preferred method for identifying advanced HIV disease, but WHO clinical staging still serves as the primary tool when CD4 counts aren’t available. A 2014 systematic review found that using WHO Stage 3 or 4 to predict a CD4 count below 200 cells per cubic millimeter was about 60% sensitive and 73% specific. In other words, clinical staging catches most people with severely weakened immune systems, but it’s not a perfect substitute for blood work.
Stage 1: No Symptoms
A person in Stage 1 feels healthy. They have no symptoms related to HIV, or their only finding is persistent generalized lymphadenopathy, which means swollen lymph nodes at two or more sites (not counting the groin) lasting longer than six months. Many people remain in Stage 1 for years after infection without knowing they carry the virus. This is one reason routine testing matters: the absence of symptoms says nothing about whether someone can transmit HIV to others.
Stage 2: Mild Symptoms
Stage 2 marks the beginning of noticeable health changes, though they’re relatively minor. Common conditions at this stage include moderate unexplained weight loss (under 10% of body weight), recurring upper respiratory infections like sinusitis, and minor skin and mouth problems such as fungal nail infections, mouth ulcers, and angular cheilitis (cracking at the corners of the mouth). Shingles, caused by reactivation of the chickenpox virus, is also a classic Stage 2 event.
These conditions aren’t unique to HIV. Most of them occur in people with healthy immune systems too. What distinguishes them in the context of HIV is their persistence or recurrence, which signals that the immune system is starting to lose ground.
Stage 3: Advanced Symptoms
Stage 3 represents a significant decline in immune function. The defining threshold for weight loss increases to more than 10% of body weight without another explanation. Chronic diarrhea lasting longer than one month, persistent fever lasting longer than one month, and oral candidiasis (thrush) are hallmark conditions.
Pulmonary tuberculosis is one of the most important Stage 3 diagnoses because TB is the leading cause of death among people living with HIV worldwide. Severe bacterial infections, including pneumonia and meningitis, also fall into this category. Unexplained anemia, low white blood cell counts, and low platelet counts that persist for more than a month are additional markers.
At Stage 3, the body is clearly struggling to fight infections it would normally control. People at this stage often feel noticeably unwell and may have difficulty maintaining their normal daily activities and weight.
Stage 4: Severe or AIDS-Defining Illnesses
Stage 4 corresponds to what most people know as AIDS. It’s defined by a list of serious opportunistic infections and cancers that only take hold when the immune system is profoundly damaged. The WHO consensus defines advanced HIV disease as a CD4 count at or below 200 cells per cubic millimeter, and mortality rises sharply below this level.
Some Stage 4 conditions can be identified through clinical signs alone:
- HIV wasting syndrome: severe weight loss with chronic diarrhea or fever and no other explanation
- Pneumocystis pneumonia (PCP): a fungal lung infection that causes progressive shortness of breath
- Cryptococcal meningitis: a fungal infection of the brain’s lining, causing severe headache and confusion
- Toxoplasmosis of the brain: a parasitic infection causing seizures, weakness, or personality changes
- Kaposi sarcoma: a cancer causing purple or brown skin lesions, often on the legs or face
- Chronic herpes simplex infections: ulcers of the mouth, genitals, or rectum lasting more than one month
- TB outside the lungs: tuberculosis spreading to the bones, lymph nodes, brain, or other organs
- Recurrent severe bacterial pneumonia: more than two episodes within a single year
Other Stage 4 conditions require lab confirmation. These include candidiasis of the esophagus or airways (thrush that spreads deep into the throat and lungs), cytomegalovirus infection affecting the eyes or organs, invasive cervical cancer, certain lymphomas, and prolonged parasitic infections like cryptosporidiosis causing diarrhea for over a month. Visceral leishmaniasis and progressive multifocal leukoencephalopathy (a brain infection causing vision loss and coordination problems) round out the list.
How Staging Differs for Children
The WHO maintains a parallel staging system for children because HIV progresses differently in young immune systems. The four stages follow the same general pattern, but the specific conditions differ. Children are more likely to present with recurring ear infections, chronic lung disease, growth faltering, and developmental delays rather than the adult pattern of weight loss and TB. Infants under five are classified as having advanced disease at the same CD4 threshold of 200 cells per cubic millimeter as adults.
In resource-limited settings, WHO recommends using clinical staging alongside whatever lab monitoring is available for children on treatment. More frequent CD4 checks are recommended when a child shows new symptoms, fails to grow, or falls behind developmentally. Importantly, the inability to perform lab monitoring should never prevent a child from starting antiretroviral treatment.
What Staging Means for Treatment Decisions
Current WHO guidelines recommend antiretroviral therapy for all people living with HIV regardless of stage. This “treat all” approach replaced earlier guidelines that used staging to determine eligibility. However, staging still matters because it tells clinicians how urgently to act and what complications to screen for. Someone diagnosed at Stage 4 needs immediate attention to both start antiretroviral treatment and manage whatever opportunistic infection brought them in.
Staging also helps predict outcomes. People who start treatment at Stage 1 or 2 have significantly better long-term survival than those who begin at Stage 3 or 4, largely because immune damage that occurs before treatment begins is only partially reversible. The practical takeaway is that earlier diagnosis translates directly into better health outcomes, regardless of where in the world someone lives.